CL2017002998A1 - Plantas que tienen expresión modificada de thca sintasa - Google Patents

Plantas que tienen expresión modificada de thca sintasa

Info

Publication number
CL2017002998A1
CL2017002998A1 CL2017002998A CL2017002998A CL2017002998A1 CL 2017002998 A1 CL2017002998 A1 CL 2017002998A1 CL 2017002998 A CL2017002998 A CL 2017002998A CL 2017002998 A CL2017002998 A CL 2017002998A CL 2017002998 A1 CL2017002998 A1 CL 2017002998A1
Authority
CL
Chile
Prior art keywords
plants
modified
expression
invention refers
thca
Prior art date
Application number
CL2017002998A
Other languages
English (en)
Inventor
Ekaterina Alexandra Boudko
Thomas Shipley Iv
Douglas Johnson
Original Assignee
Tweed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tweed Inc filed Critical Tweed Inc
Publication of CL2017002998A1 publication Critical patent/CL2017002998A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007—Tetrahydrocannabinolic acid synthase (1.21.3.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)

Abstract

<p>LA INVENCIÓN SE REFIERE A NUEVAS PLANTAS GENÉTICAMENTE MODIFICADAS Y MÉTODOS O MATERIALES, TALES COMO POLINUCLEÓTIDOS, CASETES DE EXPRESIÓN, O VECTORES, PARA SU PRODUCCIÓN. ADEMÁS, LA INVENCIÓN SE REFIERE A LA ALTERACIÓN DEL CONTENIDO DE CANNABINOIDES EN PLANTAS, Y A COMPOSICIONES MÉDICAS DERIVADAS DE DICHAS PLANTAS. EN PARTICULARES FORMAS DE REALIZACIÓN, LA PRESENTE INVENCIÓN SE REFIERE A PLANTAS DE CANNABIS QUE TIENEN EXPRESIÓN MODIFICADA DE ÁCIDO TETRAHIDROCANNABINÓLICO (THCA) SINTASA, Y MÉTODOS PARA MODIFICAR LA CANTIDAD DE DELTA-9—TETRAHIDOCANNABINOL (THC) Y CANNABIDIOL (CBD) EN CANNABIS, MODIFICANDO LA EXPRESIÓN DE THCA SINTASA.</p>
CL2017002998A 2015-05-28 2017-11-27 Plantas que tienen expresión modificada de thca sintasa CL2017002998A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562167462P 2015-05-28 2015-05-28

Publications (1)

Publication Number Publication Date
CL2017002998A1 true CL2017002998A1 (es) 2018-03-09

Family

ID=57393331

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002998A CL2017002998A1 (es) 2015-05-28 2017-11-27 Plantas que tienen expresión modificada de thca sintasa

Country Status (14)

Country Link
US (2) US10934554B2 (es)
EP (1) EP3302033A4 (es)
JP (1) JP2018519853A (es)
KR (1) KR20180021718A (es)
CN (1) CN107846861A (es)
AU (1) AU2016269328A1 (es)
BR (1) BR112017025388A2 (es)
CA (1) CA2986666A1 (es)
CL (1) CL2017002998A1 (es)
HK (1) HK1252151A1 (es)
IL (2) IL255900B (es)
MX (1) MX2017015304A (es)
RU (1) RU2017146186A (es)
WO (1) WO2016189384A1 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1252151A1 (zh) * 2015-05-28 2019-05-17 Tweed Inc. Thca合成酶表达改变的大麻植物
AU2016275186A1 (en) * 2015-06-12 2018-02-01 Anandia Laboratories Inc. Methods and compositions for cannabis characterization
EP3500090A4 (en) * 2016-08-18 2020-01-08 Canopy Growth Corporation PLANTS AND METHODS FOR INCREASING AND DECREASING CANNABINOID SYNTHESIS
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CN106591359B (zh) * 2017-02-13 2019-10-25 黑龙江省科学院大庆分院 一种大麻THCA合成酶基因RNAi载体的构建方法
AU2018239671B2 (en) * 2017-03-24 2024-08-15 Trait Biosciences, Inc. High level In vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
WO2019070876A2 (en) * 2017-10-03 2019-04-11 The Regents Of The University Of Colorado METHOD FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES
GB2568032B (en) 2017-10-25 2023-03-15 Cell Science Holdings Ltd A method of production of phytocannabinoids for use in medical treatments
WO2019090017A1 (en) * 2017-11-02 2019-05-09 Yield10 Bioscience, Inc. Genes and gene combinations for enhanced crops
US11035010B2 (en) 2017-12-14 2021-06-15 Medicinal Genomics Corporation Methods and kits for classifying cannabinoid production in cannabis plants
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
JP7293561B2 (ja) 2018-02-20 2023-06-20 マイエムディー ファーマスーティカルズ、インコーポレイテッド 薬物中毒および他の障害の治療のための遺伝子組み換え大麻植物および組み換えカンナビノイド化合物
BR112020020850A2 (pt) 2018-04-09 2021-01-19 Ellevet Sciences Extrato de cânhamo para tratamento da dor em animais
US11827892B2 (en) 2018-06-07 2023-11-28 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Nucleic acid constructs and methods of using same
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3105433C (en) * 2018-08-17 2023-07-11 Canbreed Ltd. Cannabis plant cells with reduced delta-9-tetrahydrocannabinol (thc) content
CN109122306A (zh) * 2018-08-20 2019-01-04 杭州昶胜电子商务有限公司 一种获得高大麻二酚含量工业大麻植株的方法
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
MX2021005475A (es) * 2018-11-09 2021-09-08 Agriculture Victoria Serv Pty Plantas de cannabis con un perfil de cannabinoides enriquecido con ¿-9-tetrahidrocannabinol, cannabigerol y tetrahidrocannabivari na.
US10653085B1 (en) * 2018-12-21 2020-05-19 Charlotte's Web, Inc. Hemp plant named ‘CW1AS1’
WO2020176547A1 (en) 2019-02-25 2020-09-03 Ginkgo Bioworks, Inc. Biosynthesis of cannabinoids and cannabinoid precursors
WO2020176806A1 (en) 2019-02-27 2020-09-03 3-Delta, Inc. Compositions that contain lipophilic plant material and surfactant, and related methods
WO2020183352A1 (en) * 2019-03-12 2020-09-17 Radient Technologies Innovations Inc. Time specific bioavailability of extract in consumable
SG11202111309RA (en) * 2019-04-11 2021-11-29 Kah Meng Lim Process for producing a genetically modified seed
CA3087007A1 (en) * 2019-07-17 2021-01-17 Wisconsin Alumni Research Foundation Methods of gene editing and transforming cannabis
EP4017516A4 (en) * 2019-08-23 2023-07-12 Canopy Growth Corporation METHODS FOR REDUCING THE THC CONTENT OF COMPLEX CANNABINOID MIXTURES IN WHICH THC IS A MINOR COMPONENT
CN110419397A (zh) * 2019-09-06 2019-11-08 黑龙江汉美生工业大麻科技有限公司 一种提高龙大麻5号cbd含量的种植管理方法
WO2021046154A1 (en) * 2019-09-06 2021-03-11 James Berman Genetic modification of plants
CN114829381A (zh) * 2019-10-01 2022-07-29 恩派瑞安神经科学公司 经遗传修饰的植物以及其制造方法
JP2022550585A (ja) * 2019-10-01 2022-12-02 エンピリアン ニューロサイエンス， インコーポレイテッド 遺伝子改変植物及びそれを作製する方法
KR20220079578A (ko) * 2019-10-11 2022-06-13 내셔널 유니버시티 오브 싱가포르 신규 칸나비노이드 신타아제를 사용한 칸나비게롤산으로부터 칸나비노이드의 생합성
US20230125534A1 (en) * 2019-11-04 2023-04-27 Agriculture Victoria Services Pty Ltd A Method to Produce Targeted Gene Editing Constructs
CN110923242B (zh) * 2019-12-14 2021-04-13 厦门梓蔓生物科技有限公司 一种大麻腺毛中分离的转录因子CsAPL1及其应用
EP3841872A1 (en) 2019-12-28 2021-06-30 Ploidy and Genomics SL. In vitro direct regeneration of polyploid cannabis plants
WO2021138423A1 (en) * 2019-12-30 2021-07-08 Arcadia Biosciences, Inc. Methods for genetically modifying cannabis plants, modified cannabis plants, and products therefrom
WO2021097496A2 (en) * 2020-03-10 2021-05-20 Phylos Bioscience, Inc. Autoflowering markers
MX2023000133A (es) * 2020-07-13 2023-02-09 Betterseeds Ltd Cannabis con contenido de cannabinoides alterado.
US12264296B2 (en) 2020-09-02 2025-04-01 Michael V. Zumpano Compositions that contain lipophilic plant material and surfactant, and related methods
WO2022066754A1 (en) * 2020-09-22 2022-03-31 Growing Together Research Inc. Genetically modified cannabis plants with novel phenotypes
US12029720B2 (en) 2021-04-29 2024-07-09 Tilray Brands, Inc. Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
EP4381055A4 (en) * 2021-08-06 2025-05-28 Phylos Bioscience, Inc. VARIN GENES
CA3231272A1 (en) * 2021-09-09 2023-03-16 Lennon James Matchett-Oates Methods for the modification of cells, modified cells and uses thereof
CN114214339A (zh) * 2021-12-08 2022-03-22 福建农林大学 一种汉麻thcsas2基因及其编码产物萜烯酚酸氧化环化酶与应用
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
US20230265444A1 (en) * 2022-02-24 2023-08-24 Canopy Growth Corporation Gene-editing in cannabis plant
US20250230451A1 (en) * 2022-04-05 2025-07-17 Genkore Inc. Composition comprising gene editing protein for cannabis sativa gene editing, and gene editing method using same
USPP35571P2 (en) 2023-05-05 2024-01-09 Phat Panda LLC Cannabis plant named ‘AC/DC x Redneck Wedding 13’

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE212671T1 (de) * 1991-08-01 2002-02-15 Large Scale Biology Corp Rekombinierte virale nukleinsäure aus pflanzen
JP2002512188A (ja) 1998-04-21 2002-04-23 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗酸化剤及び神経保護剤としてのカンナビノイド類
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
WO2003015700A2 (en) 2001-08-15 2003-02-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Novel vasoconstrictor cannabinoid analogs
GB2439393B (en) 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
US9035130B2 (en) * 2007-05-31 2015-05-19 Gw Pharma Limited Reference plant, a method for its production, extracts obtained therefrom and their use
GB2450741A (en) 2007-07-05 2009-01-07 Gw Pharma Ltd Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
GB2471987B (en) 2008-06-04 2012-02-22 Gw Pharma Ltd Anti-tumoural effects of cannabinoid combinations
WO2010012506A1 (en) 2008-07-31 2010-02-04 Bionorica Research Gmbh Cannabinoids for use in treating or preventing cognitive impairment and dementia
US8884100B2 (en) 2009-08-12 2014-11-11 National Research Council Of Canada Aromatic prenyltransferase from Cannabis
CA3130705A1 (en) 2010-04-15 2011-10-20 National Research Council Of Canada Genes and proteins for aromatic polyketide synthesis
US20120311744A1 (en) 2011-06-06 2012-12-06 Erich E. Sirkowski Marked Cannabis For Indicating Medical Marijuana
WO2013006953A1 (en) 2011-07-13 2013-01-17 National Research Council Of Canada Genes and proteins for alkanoyl-coa synthesis
WO2014145490A2 (en) * 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
US10441617B2 (en) * 2013-03-15 2019-10-15 Biotech Institute, Llc Breeding, production, processing and use of medical cannabis
US20150098954A1 (en) 2013-10-08 2015-04-09 Elwha Llc Compositions and Methods Related to CRISPR Targeting
US9546960B2 (en) 2014-11-14 2017-01-17 Lightwave Science, Inc. System and method for analysis of cannabis
HK1252151A1 (zh) * 2015-05-28 2019-05-17 Tweed Inc. Thca合成酶表达改变的大麻植物

Also Published As

Publication number Publication date
RU2017146186A (ru) 2019-06-28
KR20180021718A (ko) 2018-03-05
JP2018519853A (ja) 2018-07-26
EP3302033A1 (en) 2018-04-11
WO2016189384A1 (en) 2016-12-01
RU2017146186A3 (es) 2019-11-18
BR112017025388A2 (pt) 2018-08-07
AU2016269328A1 (en) 2017-12-07
EP3302033A4 (en) 2018-10-31
US20180258439A1 (en) 2018-09-13
CN107846861A (zh) 2018-03-27
IL255900A (en) 2018-01-31
US10934554B2 (en) 2021-03-02
IL281500A (en) 2021-04-29
MX2017015304A (es) 2018-07-06
HK1252151A1 (zh) 2019-05-17
CA2986666A1 (en) 2016-12-01
IL255900B (en) 2021-04-29
US20210207154A1 (en) 2021-07-08
IL281500B (en) 2021-12-01

Similar Documents

Publication Publication Date Title
MX2017015304A (es) Plantas de cannabis que tienen expresion modificada de acido tetrahidrocannabinolico sintasa.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
MX2016010216A (es) Composiciones farmaceuticas solidas de antagonistas de los receptores de androgenos.
MX2021010033A (es) Composiciones microencapsuladas de cannabinoides.
CL2017003456A1 (es) Metodos para tratar tumores de celulas epitelioides
BR112019001794A2 (pt) composição de cannabis
BR112017008301A2 (pt) extratos de cannabis e métodos de sua preparação e uso
UY36705A (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
DK3258942T3 (da) Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol
MX381376B (es) Preparaciones terapéuticas de glicanos y métodos relacionados con estas.
CL2018002671A1 (es) 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonistas del receptor de apelina (apj)
MX2017016345A (es) Proteinas de fusion para inhibir la angiogenesis.
BR112017021191A2 (pt) um extrato de indigo naturalis e um processo para preparar o mesmo
MX2016014509A (es) Formulacion de vitamina soluble en grasa.
ECSP14013302A (es) Composiciones de yodo-povidona estable
CL2016000063A1 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
BR112018003864A2 (pt) método para preparação de uma composição de ácido hialurônico, composição, e, método para restauração de um tecido
BR112017010177A2 (pt) composição para tratamento de tecido
MX2017004998A (es) Composicion que contiene un extracto o fraccion de una planta del genero justicia.
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
BR112017021190A2 (pt) composição farmacêutica e o uso da mesma
CR20170090A (es) Derivados de terahidroquinolina como inhibidores del bromodominio
IL259891A (en) Organic solvent free compositions comprising protein-polymer conjugates and uses thereof